Evanston, IL, United States of America

Pathum Manjula Weerawarna

This inventor holds 1 USPTO granted patent. Top assignee: Northwestern University. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pathum Manjula Weerawarna. Retrieved from https://idiyas.com/inventor/pathum-manjula-weerawarna

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pathum Manjula Weerawarna: Innovator in Bacterial Nitric Oxide Synthase Inhibitors

Introduction

Pathum Manjula Weerawarna is a notable inventor based in Evanston, Illinois. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit bacterial nitric oxide synthase.

Latest Patents

Weerawarna holds a patent for "Bacterial nitric oxide synthase inhibitors." This patent discloses substituted aminoquinoline and aminopyridine compounds, which are utilized as inhibitors of bacterial nitric oxide synthase (bNOS). The patent also includes pharmaceutical compositions comprising these compounds and outlines methods for using them to treat diseases or disorders associated with bNOS activity.

Career Highlights

Weerawarna is affiliated with Northwestern University, where he engages in research and development in the field of pharmacology. His work focuses on creating innovative solutions to combat bacterial infections and related health issues.

Collaborations

One of his notable collaborators is Richard B Silverman, who is also involved in research at Northwestern University. Their partnership has contributed to advancements in the understanding and application of bNOS inhibitors.

Conclusion

Pathum Manjula Weerawarna's work in developing bacterial nitric oxide synthase inhibitors represents a significant advancement in medicinal chemistry. His contributions are poised to impact the treatment of various diseases linked to bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…